Literature DB >> 24027305

Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.

Pedro Piccardo1, Declan King, Glenn Telling, Jean C Manson, Rona M Barron.   

Abstract

Misfolding and aggregation of proteins are common pathogenic mechanisms of a group of diseases called proteinopathies. The formation and spread of proteinaceous lesions within and between individuals were first described in prion diseases and proposed as the basis of their infectious nature. Recently, a similar "prion-like" mechanism of transmission has been proposed in other neurodegenerative diseases such as Alzheimer's disease. We investigated if misfolding and aggregation of corrupted prion protein (PrP(TSE)) are always associated with horizontal transmission of disease. Knock-in transgenic mice (101LL) expressing mutant PrP (PrP-101L) that are susceptible to disease but do not develop any spontaneous neurological phenotype were inoculated with (i) brain extracts containing PrP(TSE) from healthy 101LL mice with PrP plaques in the corpus callosum or (ii) brain extracts from mice overexpressing PrP-101L with neurological disease, severe spongiform encephalopathy, and formation of proteinase K-resistant PrP(TSE). In all instances, 101LL mice developed PrP plaques in the area of inoculation and vicinity in the absence of clinical disease or spongiform degeneration of the brain. Importantly, 101LL mice did not transmit disease on serial passage, ruling out the presence of subclinical infection. Thus, in both experimental models the formation of PrP(TSE) is not infectious. These results have implications for the interpretation of tests based on the detection of protein aggregates and suggest that de novo formation of PrP(TSE) in the host does not always result in a transmissible prion disease. In addition, these results question the validity of assuming that all diseases due to protein misfolding can be transmitted between individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027305      PMCID: PMC3807897          DOI: 10.1128/JVI.00673-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

2.  Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice.

Authors:  Karah E Nazor; Franziska Kuhn; Tanya Seward; Mike Green; Daniel Zwald; Mario Pürro; Jaqueline Schmid; Karin Biffiger; Aisling M Power; Bruno Oesch; Alex J Raeber; Glenn C Telling
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

3.  Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies.

Authors:  Emiliano Biasini; M Esa Seegulam; Brianna N Patti; Laura Solforosi; Andrea Z Medrano; Heather M Christensen; Assunta Senatore; Roberto Chiesa; R Anthony Williamson; David A Harris
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

4.  Protease-resistant prion protein produced in vitro lacks detectable infectivity.

Authors:  A F Hill; M Antoniou; J Collinge
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

5.  Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

6.  Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro.

Authors:  Nathan R Deleault; Richard Kascsak; James C Geoghegan; Surachai Supattapone
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

7.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

8.  Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages.

Authors:  Richard Race; Kimberly Meade-White; Anne Raines; Gregory J Raymond; Byron Caughey; Bruce Chesebro
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

9.  Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.

Authors:  Michael B Miller; James C Geoghegan; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

10.  Molecular distinction between pathogenic and infectious properties of the prion protein.

Authors:  Roberto Chiesa; Pedro Piccardo; Elena Quaglio; Bettina Drisaldi; San Ling Si-Hoe; Masaki Takao; Bernardino Ghetti; David A Harris
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  13 in total

Review 1.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

2.  Infectious prions and proteinopathies.

Authors:  Rona M Barron
Journal:  Prion       Date:  2017-01-02       Impact factor: 3.931

3.  Transmission characteristics of variably protease-sensitive prionopathy.

Authors:  Silvio Notari; Xiangzhu Xiao; Juan Carlos Espinosa; Yvonne Cohen; Liuting Qing; Patricia Aguilar-Calvo; Diane Kofskey; Ignazio Cali; Laura Cracco; Qingzhong Kong; Juan Maria Torres; Wenquan Zou; Pierluigi Gambetti
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

4.  Transcriptome analysis of CNS immediately before and after the detection of PrP(Sc) in SSBP/1 sheep scrapie.

Authors:  Anton G Gossner; John Hopkins
Journal:  Vet Microbiol       Date:  2014-08-15       Impact factor: 3.293

5.  Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties.

Authors:  Abigail B Diack; Diane L Ritchie; Alexander H Peden; Deborah Brown; Aileen Boyle; Laura Morabito; David Maclennan; Paul Burgoyne; Casper Jansen; Richard S Knight; Pedro Piccardo; James W Ironside; Jean C Manson
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

6.  Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.

Authors:  Fei Wang; Xinhe Wang; Christina D Orrú; Bradley R Groveman; Krystyna Surewicz; Romany Abskharon; Morikazu Imamura; Takashi Yokoyama; Yong-Sun Kim; Kayla J Vander Stel; Kumar Sinniah; Suzette A Priola; Witold K Surewicz; Byron Caughey; Jiyan Ma
Journal:  PLoS Pathog       Date:  2017-07-12       Impact factor: 6.823

Review 7.  Insights into Mechanisms of Chronic Neurodegeneration.

Authors:  Abigail B Diack; James D Alibhai; Rona Barron; Barry Bradford; Pedro Piccardo; Jean C Manson
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

8.  PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.

Authors:  Rona M Barron; Declan King; Martin Jeffrey; Gillian McGovern; Sonya Agarwal; Andrew C Gill; Pedro Piccardo
Journal:  Acta Neuropathol       Date:  2016-07-04       Impact factor: 17.088

9.  Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.

Authors:  Laura Pirisinu; Michele A Di Bari; Claudia D'Agostino; Stefano Marcon; Geraldina Riccardi; Anna Poleggi; Mark L Cohen; Brian S Appleby; Pierluigi Gambetti; Bernardino Ghetti; Umberto Agrimi; Romolo Nonno
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

10.  A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.

Authors:  Robert C C Mercer; Nathalie Daude; Lyudmyla Dorosh; Ze-Lin Fu; Charles E Mays; Hristina Gapeshina; Serene L Wohlgemuth; Claudia Y Acevedo-Morantes; Jing Yang; Neil R Cashman; Michael B Coulthart; Dawn M Pearson; Jeffrey T Joseph; Holger Wille; Jiri G Safar; Gerard H Jansen; Maria Stepanova; Brian D Sykes; David Westaway
Journal:  PLoS Pathog       Date:  2018-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.